SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Electric discovery on Mars! Scientists find tiny lightning bolts coming from Red Planet dust clouds - 2Woman gives birth on roadside after hospital allegedly sent her home: Family
- 3Italy Brings In New Measures In 2026 To Tackle Overtourism
- 4Merz visit highlights new strategic, and strained, Germany-Israel bond
- 5Reconnecting with an old friend is a story of distance, loss and rediscovery
- Climate change is straining Alaska's Arctic. A new mining road may push the region past the brink
- Some are walking out. Some are shouting. Some are oblivious. How kids are reacting to THAT 'Wicked: For Good' scene
- Kennedy approves adding two rare disorders to newborn screenings
- Cameroon says Russia has confirmed 16 Cameroonian soldiers died in Ukraine
- Joshua Made Last-Second Seat Change That Saved His Life
- NASA is sending astronauts back to the moon. Can you see the Artemis 4 landing sites from Earth?
- Catch the moon dancing with bright star Regulus tonight
- Upgrading the Healthy benefit of Your Local Vegetables
- 6 Solid Vehicle Fix Administrations to Keep Your Vehicle in Prime Condition
